Idarubicin and cyclophosphamide--an active oral chemotherapy regimen for advanced breast cancer. (Record no. 10668874)

MARC details
000 -LEADER
fixed length control field 01592 a2200433 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513204120.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200004s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1040-8428
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/s1040-8428(99)00042-6
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Leonard, R C
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20000412
245 00 - TITLE STATEMENT
Title Idarubicin and cyclophosphamide--an active oral chemotherapy regimen for advanced breast cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Critical reviews in oncology/hematology
Date of publication, distribution, etc. Jan 2000
300 ## - PHYSICAL DESCRIPTION
Extent 61-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Congress; Multicenter Study
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Oral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Agranulocytosis
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibiotics, Antineoplastic
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclophosphamide
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Disease Progression
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fatigue
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Idarubicin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infections
General subdivision chemically induced
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thrombocytopenia
General subdivision chemically induced
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Cameron, D A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Anderson, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ostrowski, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Howell, A
773 0# - HOST ITEM ENTRY
Title Critical reviews in oncology/hematology
Related parts vol. 33
-- no. 1
-- p. 61-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/s1040-8428(99)00042-6">https://doi.org/10.1016/s1040-8428(99)00042-6</a>
Public note Available from publisher's website

No items available.